Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
bristol-myers squibb
intercept pharmaceuticals
life sciences
liver
2
×
nash
2
×
national blog main
2
×
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
2
×
san francisco top stories
2019
activism
acute hepatic porphyria
allergan
alnylam pharmaceuticals
bernie sanders
biotech
boulder/denver blog main
boulder/denver top stories
buyout
celgene
charges
clinical data
clinical trials
congress
crisis
detroit blog main
detroit top stories
drug prices
easl
fatty liver disease
genfit
gilead sciences
givosiran
house of representatives
What
disease
drug
liver
advanced
alnylam’s
approval
approved
bff
bio
conference
data
deals
devoted
easl
fatty
form
gene
horizon
intercept
kicked
known
major
marketed
medicine
nash
new
nonalcoholic
race
roundup
steatohepatitis
therapy
track
treat
updates
world's
Language
Current search:
liver
×
nash
×
" san francisco blog main "
×
" national blog main "
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug